One of the things that I like (and occasionally dislike)
about the field of glaucoma is the fact that
there is never a dull moment in the management
of this challenging disease. Even the seemingly
perfect surgery can produce problems just a li…
The Navilas laser system (OD-OS Inc., San Francisco,
CA) offers improved visualization, ergonomics, and imaging
over traditional retinal laser therapy, and it helps with
treatment planning and execution, Richard Rosen, MD,
said at meeting of the Europe…
Both 23- and 25-gauge microincisional vitrectomy surgery
(MIVS) with the Constellation Vision System (Alcon
Laboratories Inc., Fort Worth, TX) may be effectively
combined with phacoemulsification without significant
increases in preoperative or postope…
Applied Genetic Technologies Corporation
(Gainesville, FL) announced that it has received a
$1 million grant from the FDA through its Orphan Drugs
Program to fund a phase 2 human clinical trial evaluating
the safety and efficacy of a treatment for Lebe…
The US Food and Drug Administration (FDA) has
approved Ozurdex (dexamethasone intravitreal implant
0.7 mg; Allergan, Inc.) for the treatment of noninfectious
uveitis affecting the posterior segment, according to a
company news release.
Ozurdex is a bio…
At the American Society of Retina Specialists (ASRS)
meeting in Vancouver, P. Andrew Pearson, MD, provided
an update on the phase 3 clinical trials, collectively
known as the FAME study, involving the Iluvien (Alimera
Sciences, Inc.) intravitreal inser…